JP2007504863A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007504863A5 JP2007504863A5 JP2006525566A JP2006525566A JP2007504863A5 JP 2007504863 A5 JP2007504863 A5 JP 2007504863A5 JP 2006525566 A JP2006525566 A JP 2006525566A JP 2006525566 A JP2006525566 A JP 2006525566A JP 2007504863 A5 JP2007504863 A5 JP 2007504863A5
- Authority
- JP
- Japan
- Prior art keywords
- app
- binding
- peptide
- antibody
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108010079054 Amyloid beta-Protein Precursor Proteins 0.000 claims 10
- 102000018430 Amyloid-beta precursor proteins Human genes 0.000 claims 10
- 108090000765 processed proteins & peptides Proteins 0.000 claims 7
- 102100039358 3-hydroxyacyl-CoA dehydrogenase type-2 Human genes 0.000 claims 3
- 101001035740 Homo sapiens 3-hydroxyacyl-CoA dehydrogenase type-2 Proteins 0.000 claims 3
- 102000023732 binding proteins Human genes 0.000 claims 2
- 108091008324 binding proteins Proteins 0.000 claims 2
- 150000002270 gangliosides Chemical class 0.000 claims 2
- 239000007787 solid Substances 0.000 claims 2
- KEWSCDNULKOKTG-UHFFFAOYSA-N 4-cyano-4-ethylsulfanylcarbothioylsulfanylpentanoic acid Chemical compound CCSC(=S)SC(C)(C#N)CCC(O)=O KEWSCDNULKOKTG-UHFFFAOYSA-N 0.000 claims 1
- 101150037123 APOE gene Proteins 0.000 claims 1
- 208000024827 Alzheimer disease Diseases 0.000 claims 1
- 102100037637 Cholesteryl ester transfer protein Human genes 0.000 claims 1
- 101100216294 Danio rerio apoeb gene Proteins 0.000 claims 1
- 102000004878 Gelsolin Human genes 0.000 claims 1
- 108090001064 Gelsolin Proteins 0.000 claims 1
- 101000880514 Homo sapiens Cholesteryl ester transfer protein Proteins 0.000 claims 1
- 101100440173 Mus musculus Clu gene Proteins 0.000 claims 1
- 238000002617 apheresis Methods 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AT0144403A AT413336B (de) | 2003-09-12 | 2003-09-12 | Apherese-vorrichtung |
| PCT/AT2004/000311 WO2005025651A1 (de) | 2003-09-12 | 2004-09-13 | Apherese-vorrichtung |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007504863A JP2007504863A (ja) | 2007-03-08 |
| JP2007504863A5 true JP2007504863A5 (enExample) | 2010-03-25 |
| JP4509113B2 JP4509113B2 (ja) | 2010-07-21 |
Family
ID=34280361
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006525566A Expired - Fee Related JP4509113B2 (ja) | 2003-09-12 | 2004-09-13 | アフェレーシス装置 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US7935252B2 (enExample) |
| EP (1) | EP1663347B1 (enExample) |
| JP (1) | JP4509113B2 (enExample) |
| CN (1) | CN100556472C (enExample) |
| AT (2) | AT413336B (enExample) |
| AU (1) | AU2004271651B2 (enExample) |
| CA (1) | CA2538305C (enExample) |
| CY (1) | CY1107911T1 (enExample) |
| DE (1) | DE502004005851D1 (enExample) |
| DK (1) | DK1663347T3 (enExample) |
| ES (1) | ES2298789T3 (enExample) |
| HR (1) | HRP20080090T3 (enExample) |
| PL (1) | PL1663347T3 (enExample) |
| PT (1) | PT1663347E (enExample) |
| WO (1) | WO2005025651A1 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003303198A1 (en) | 2002-12-19 | 2004-07-14 | New York University | Method for treating amyloid disease |
| AT500483B1 (de) | 2004-07-13 | 2006-01-15 | Mattner Frank Dr | Set zur vorbeugung oder behandlung der alzheimer'schen erkrankung |
| AT501621A1 (de) * | 2005-03-15 | 2006-10-15 | Mattner Frank Dr | Zusammensetzungen zur verwendung bei der vorbeugung und behandlung der alzheimer- erkrankung |
| ES2332846B1 (es) * | 2007-10-26 | 2010-07-08 | Grifols, S.A. | Utilizacion de albumina humana terapeutica para la preparacion de un medicamento para el tratamiento de pacientes afectados por desordenes cognitivos. |
| EP2237804B1 (en) * | 2007-12-21 | 2013-04-10 | GE Healthcare Bio-Sciences AB | Method for sterilization of chemically activated solid support materials |
| WO2010014702A1 (en) * | 2008-07-29 | 2010-02-04 | Medtronic, Inc. | Apheresis of a target molecule from cerebrospinal fluid |
| US20100158893A1 (en) * | 2008-12-19 | 2010-06-24 | Baxter International Inc. | Systems and methods for obtaining immunoglobulin from blood |
| KR101538361B1 (ko) * | 2008-12-22 | 2015-07-22 | 후지타 헬쓰 유니버시티 | Ａβ 제거재, Ａβ 제거기 및 Ａβ 제거 시스템 |
| US20110033463A1 (en) * | 2009-08-06 | 2011-02-10 | Medtronic, Inc. | Apheresis, administration of agent, or combination thereof |
| EP2497828A1 (en) * | 2011-03-07 | 2012-09-12 | Charité - Universitätsmedizin Berlin | Use of aptamers in therapy and/or diagnosis of autoimmune diseases |
| RS53496B1 (sr) | 2011-10-04 | 2015-02-27 | Affiris Ag | POSTUPAK ZA DETEKCIJU Aβ-SPECIFIČNIH ANTITELA U BIOLOŠKOM UZORKU |
| US9717841B2 (en) | 2012-09-11 | 2017-08-01 | Gary L. McNeil | Closed-circuit device and methods for isolation, modification, and re-administration of specific constituents from a biological fluid source |
| AU2015286604B2 (en) | 2014-07-10 | 2019-08-15 | Hd Immune Gmbh | Substances and methods for the use in prevention and/or treatment in Huntington's disease |
| AU2015286606A1 (en) | 2014-07-10 | 2017-01-12 | Affiris Ag | Substances and methods for the use in prevention and/or treatment in huntington's disease |
| US12227567B2 (en) | 2017-07-25 | 2025-02-18 | Truebinding, Inc. | Treating cancer by blocking the interaction of TIM-3 and its ligand |
| CN116063520A (zh) | 2019-01-30 | 2023-05-05 | 真和制药有限公司 | 抗gal3抗体及其用途 |
| GB201904810D0 (en) * | 2019-04-05 | 2019-05-22 | Cynapsedx Ltd | The treatment of protein aggregation diseases |
| CN116157151A (zh) | 2020-05-26 | 2023-05-23 | 真和制药有限公司 | 通过阻断半乳凝素-3治疗炎性疾病的方法 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57103649A (en) * | 1980-12-18 | 1982-06-28 | Asahi Chemical Ind | Sterilized gamma-globulin fixing column |
| EP0236509B1 (en) | 1985-09-19 | 1993-02-10 | Toray Industries, Inc. | B2-microglobulin-removing column |
| US5216127A (en) * | 1987-11-20 | 1993-06-01 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Adsorbent for serum amyloid protein |
| JPH01171638A (ja) * | 1987-12-25 | 1989-07-06 | Kanegafuchi Chem Ind Co Ltd | 血清アミロイドａ蛋白用吸着体 |
| EP0321703B1 (en) * | 1987-11-20 | 1993-04-28 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Absorbent for serum amyloid protein |
| US5604102A (en) * | 1992-04-15 | 1997-02-18 | Athena Neurosciences, Inc. | Methods of screening for β-amyloid peptide production inhibitors |
| JPH06104122A (ja) | 1992-09-21 | 1994-04-15 | Matsushita Electric Ind Co Ltd | ロータリートランス |
| ATE294959T1 (de) * | 1994-05-13 | 2005-05-15 | Miltenyi Biotec Gmbh | An protein gebundene sterile und pyrogenfreie säulen zum binden und entfernen von substanzen aus blut |
| DE19549420A1 (de) * | 1995-04-27 | 1997-09-18 | Braun Melsungen Ag | Verfahren zur simultanen extrakorporalen Elimination von Tumor-Nekrose Faktor alpha (TNF alpha) und bakteriellen Lipopolysacchariden (LPS) aus Vollblut oder/und Blutplasma |
| US5868936A (en) * | 1996-06-20 | 1999-02-09 | Baxter International Inc. | Affinity membrane system and method of using same |
| US6787523B1 (en) * | 1997-12-02 | 2004-09-07 | Neuralab Limited | Prevention and treatment of amyloidogenic disease |
| DE1257584T1 (de) | 2000-02-24 | 2003-05-28 | Lilly Co Eli | Humanisierte antikörper, die amyloid beta peptid demarkieren |
| TWI238251B (en) * | 2000-07-13 | 2005-08-21 | Anawrhta Biotech Co Ltd | In-vitro adsorbing device using immunity |
| US20050227941A1 (en) | 2001-12-17 | 2005-10-13 | Karen Duff | Sequestration of ass in the periphery in the absence of immunomodulating agent as a therapeutic approach for the treatment or prevention of beta-amyloid related diseases |
| AU2003303198A1 (en) * | 2002-12-19 | 2004-07-14 | New York University | Method for treating amyloid disease |
| AT413945B (de) * | 2003-01-14 | 2006-07-15 | Mattner Frank Dr | Impfstoff für die alzheimer-krankheit |
| AT413946B (de) * | 2004-07-13 | 2006-07-15 | Mattner Frank Dr | Impfstoff gegen die alzheimer-krankheit |
| AT500835B1 (de) * | 2004-09-13 | 2007-12-15 | Affiris Forschungs & Entwicklungs Gmbh | Cholinestertransport-protein-mimotop als atherosklerose-medikament |
-
2003
- 2003-09-12 AT AT0144403A patent/AT413336B/de not_active IP Right Cessation
-
2004
- 2004-09-13 CA CA2538305A patent/CA2538305C/en not_active Expired - Fee Related
- 2004-09-13 US US10/571,469 patent/US7935252B2/en not_active Expired - Fee Related
- 2004-09-13 WO PCT/AT2004/000311 patent/WO2005025651A1/de not_active Ceased
- 2004-09-13 ES ES04761033T patent/ES2298789T3/es not_active Expired - Lifetime
- 2004-09-13 DE DE502004005851T patent/DE502004005851D1/de not_active Expired - Lifetime
- 2004-09-13 CN CNB2004800303263A patent/CN100556472C/zh not_active Expired - Fee Related
- 2004-09-13 EP EP04761033A patent/EP1663347B1/de not_active Expired - Lifetime
- 2004-09-13 AU AU2004271651A patent/AU2004271651B2/en not_active Ceased
- 2004-09-13 PT PT04761033T patent/PT1663347E/pt unknown
- 2004-09-13 JP JP2006525566A patent/JP4509113B2/ja not_active Expired - Fee Related
- 2004-09-13 DK DK04761033T patent/DK1663347T3/da active
- 2004-09-13 AT AT04761033T patent/ATE382383T1/de active
- 2004-09-13 HR HR20080090T patent/HRP20080090T3/xx unknown
- 2004-09-13 PL PL04761033T patent/PL1663347T3/pl unknown
-
2008
- 2008-03-21 CY CY20081100330T patent/CY1107911T1/el unknown
-
2011
- 2011-03-17 US US13/049,994 patent/US20110166327A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007504863A5 (enExample) | ||
| JP2008506665A5 (enExample) | ||
| US7935348B2 (en) | Combination therapy for the treatment of Alzheimer's disease | |
| Zhang et al. | Multiple-peptide conjugates for binding β-amyloid plaques of Alzheimer's disease | |
| ATE430569T1 (de) | Neue arzneimittel zur behandlung von chronisch obstruktiver lungenerkrankung | |
| CN101420992B (zh) | 用于体外处理含粒子的液体的可再生过滤器及其应用 | |
| JP2010507432A5 (enExample) | ||
| DE60208366D1 (de) | Substituierte azabicyclische einheiten zur krankheitsbehandlung (nikotinische acetylcholinrezeptor-antagonisten) | |
| SE0401253L (sv) | Bärbar anordning för kontinuerlig venovenös hemofiltration/dialys | |
| CA2538305A1 (en) | Apheresis device | |
| EP1569691A4 (en) | DISTRIBUTION OF PHARMACEUTICAL AGENTS OVER THE HUMAN INSULIN RECEPTOR | |
| EP1949873A4 (en) | DEVICE AND METHOD FOR SUPPORTING THE MOVEMENT | |
| DK0476044T3 (da) | Anvendelse af IGF1 eller IGF2 til fremstilling af et lægemiddeltil behandling af amyotrof, lateral sklerose | |
| EA200100050A1 (ru) | Метод удаления бета-2 микроглобулина из крови | |
| CN106236446B (zh) | 一种重症监护室内固定患者并定时叫醒的装置 | |
| JP2007513079A5 (enExample) | ||
| JP2004517824A5 (enExample) | ||
| DK2841447T3 (en) | Hitherto UNKNOWN COMPOSITION FOR EXTRACORPORAL REDUCTION OF BETA AMYLOIDS AND METHOD FOR PREPARING IT | |
| EE05168B1 (et) | N-guanidinoalklamiid, meetod selle valmistamiseks, seda sisaldav farmatseutiline preparaat ning raviotstarbeline kasutamine | |
| EE04855B1 (et) | Hüübimistegurit pärssiv ühend, meetod selle valmistamiseks, seda sisaldav farmatseutiline preparaatning raviotstarbeline kasutamine | |
| EP1491210A4 (en) | THERAPEUTIC MEDICAMENT USING ANTIBODY PRESENTING HOLES PROTEIN NANOTEHICLES AND HIGH PROTEIN NANOTEHICLES | |
| FR2819810B1 (fr) | Peptides non glycosyles derives de la proteine g du vrs et leur utilisation dans un vaccin | |
| NO20010029L (no) | Anvendelse av cystein-derivater for fremstilling av en medisin for behandling av patologier som stammer fra dannelse av heterotrimert G-protein | |
| JP2004101392A5 (enExample) | ||
| KR101889564B1 (ko) | β２ｍ 단백질의 치료적 용도 |